Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Cerebral deposition of the beta-amyloid peptide (A beta) is an invariant feature of Alzheimer's disease. Since the original isolation and characterization of A beta (ref. 1) and the subsequent cloning of its precursor protein, no direct evidence for the actual production of discrete A beta has been reported. Here we investigate whether A beta is present in human biological fluids using antibodies specific for an epitope within A beta that spans the site of normal constitutive cleavage. These antibodies were used to construct a sandwich-type enzyme-linked immunosorbent assay that detects A beta in cerebrospinal fluid, plasma and conditioned medium of human mixed-brain cells grown in vitro (see also ref. 14). By affinity chromatography, we have purified and sequenced A beta and a novel A beta fragment from human cerebrospinal fluid and conditioned medium of human mixed-brain cell cultures. These findings demonstrate that A beta is produced and released both in vivo and in vitro. These observations offer new opportunities for developing diagnostic tests for Alzheimer's disease and therapeutic strategies aimed at reducing the cerebral deposition of A beta.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“studies that shed light on the physiological role of Aβ in non-diseased brains show that Aβ plays a role in synaptic transmission and is involved in learning and memory formation [18–22].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [18]
In the citing paper
“Recently, we and others have shown that normal processing of the large amyloid f3 protein precursor ({3-APP) secretes 4-kDa A(3 that is readily detected in human cerebrospinal fluid and in medium conditioned by cultured cells (3)(4)(5)(6).”
From Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain (1995) · cites this paper as [3]
In the citing paper
“The demonstration that A-related peptides with the same N terminals as the CTFs documented here are present in conditioned medium of cultured cells (Seubert et al., 1992;Naslund et al., 1994;Simons et al., 1996;Wang et al., 1996;Xu et al., 1998)”
From Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path (1998) · cites this paper as Seubert et al., 1992
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Self-citationCleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,410
Self-citationMutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,381
Self-citationChartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J., Farlow, M., Ghetti, B., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,127
Tanzi, R. E., McClatchey, A. I., Lamperti, E. D., Villa-Komaroff, L., Gusella, J. F., & Neve, R. L. (1988) · Nature · doi:10.1038/331528a0 · Cited by 1,096
Cited by
Items 1,101–1,200 of 1,726
Roselli, S., Şatır, T. M., Camacho, R., Fruhwürth, S., Bergström, P., Zetterberg, H., & Agholme, L. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01374-0 · Cited by 29
Jung, J. I., Ran, Y., Cruz, P. E., Rosario, A. M., Ladd, T. B., Kukar, T. L., Koo, E. H., Felsenstein, K. M., & Golde, T. E. (2014) · Biochemistry · doi:10.1021/bi401521t · Cited by 24
Watts, C. R., Gregory, A., Frisbie, C. P., & Lovas, S. (2017) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25439 · Cited by 22
The influence of the amyloid ß-protein and its precursor in modulating cerebral hemostasis
Nostrand, W. E. V. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.020 · Cited by 22
Zirah, S., Ştefănescu, R., Manea, M., Tian, X., Cecal, R., Kozin, S. A., Debey, P., Rebuffat, S., & Przybylski, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.150 · Cited by 22
Effects of cadmium, copper, and zinc on βAPP processing and turnover in COS-7 and PC12 cells
Smedman, M., Potempska, A., Rubenstein, R., Ju, W., Ramakrishna, N., & Denman, R. B. (1997) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815157 · Cited by 22
“Normally, the majority of ~APP is cleaved by o~-secretase, prohibiting the formation of the Alzheimer I3-peptide, A~. However, even under normal processing conditions, a small amount of A~ is formed; this indicates that ~-secretase is expressed in at least some cell lines (Haass et al., 1992; Seubert et al., 1992 ).”
Roses, A. D., Pericak‐Vance, M. A., Saunders, A. M., Schmechel, D., Goldgaber, D., & Strittmatter, W. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb05925.x · Cited by 22
Diagnosis of Alzheimer's disease: defining genetic profiles (genotype vs phenotype)
Cacabelos, R. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb05875.x · Cited by 27
Forloni, G., Bo, R. D., Angeretti, N., Smiroldo, S., Gabellini, N., & Vantini, G. (1993) · Brain Research · doi:10.1016/0006-8993(93)90168-m · Cited by 22
Widespread γ-secretase activity in the cell, but do we need it at the mitochondria?
Teng, F. Y. H., & Tang, B. L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.131 · Cited by 21
Genetic and pharmacological evidence of intraneuronal Aβ accumulation in APP transgenic mice
Philipson, O., Lannfelt, L., & Nilsson, L. N. G. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.08.009 · Cited by 21
“Endoproteolysis of amyloid-b precursor protein (APP) and subsequent secretion of Ab into the interstitial fluid may lead to fibril formation [1,2].”
BackgroundDhanjal, J. K., Goyal, S., Sharma, S., Hamid, R., & Grover, A. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.12.088 · Cited by 21
A cellular model of amyloid precursor protein processing and amyloid-β peptide production
Macias, M. P., Gonzales, A. M., Siniard, A. L., Walker, A. W., Corneveaux, J. J., Huentelman, M. J., Sabbagh, M. N., & Decourt, B. (2013) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2013.11.024 · Cited by 24
“2B) revealed the 7:1 ratio of A 40:A 42 peptides produced by 17 cells is similar to the 10:1 ratio found in the CSF of non-familial D patients (Seubert et al., 1992), and suggests the M17 in vitro sysem provides an approach to investigate the regulation of the A ntramembrane cleavage site selection.”
BackgroundMethodTakahashi, H., Fukumoto, H., Maeda, R., Terauchi, J., Kato, K., & Miyamoto, M. (2010) · Brain Research · doi:10.1016/j.brainres.2010.09.032 · Cited by 23
Colvin, B. A., Rogers, V. A., Kulas, J. A., Ridgway, E. A., Amtashar, F. S., Combs, C. K., & Nichols, M. R. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14211 · Cited by 23
“Furthermore, antibodies have allowed quantitative measurement of Aβ levels in human fluids (Seubert et al. 1992).”
Hideshima, S., Wustoni, S., Kobayashi, M., Hayashi, H., Kuroiwa, S., Nakanishi, T., & Ōsaka, T. (2018) · Sensing and Bio-Sensing Research · doi:10.1016/j.sbsr.2018.01.003 · Cited by 23
Brinkmalm, A., Portelius, E., Brinkmalm, G., Pannee, J., Dahlén, R., Gobom, J., Blennow, K., & Zetterberg, H. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14594 · Cited by 23
“In 1992, Ab was detected in human CSF (Seubert et al. 1992) followed by several studies reporting on detection of Ab1–42 as well as the C-terminally truncated Ab1–40 in CSF (Motter et al. 1995; Roher et al. 2009).”
BackgroundCholestenoic acid, an endogenous cholesterol metabolite, is a potent γ-secretase modulator
Jung, J. I., Price, A. R., Ladd, T. B., Ran, Y., Park, H.-J., Ceballos‐Diaz, C., Smithson, L. A., Hochhaus, G., Tang, Y., Akula, R., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0021-z · Cited by 25
Johnston, J. A., O’Neill, C., Lannfelt, L., Winblad, B. G., & Cowburn, R. F. (1994) · Neurochemistry International · doi:10.1016/0197-0186(94)90056-6 · Cited by 23
Satoh, Y., Hirakura, Y., Shibayama, S., Hirashima, N., Suzuki, T., & Kirino, Y. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01665-2 · Cited by 24
Yi, X., Zhang, Y., Gong, M., Yu, X., Darabedian, N., Zheng, J., & Zhou, F. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00719 · Cited by 21
β-Amyloid precursor protein gene in squirrel monkeys with cerebral amyloid angiopathy
Levy, E., Amorim, A., Frangione, B., & Walker, L. C. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00090-2 · Cited by 21
Cerebrovascular structure and dementia: new drug targets
Atkinson, J. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01866-6 · Cited by 26
Direct Evidence for Self-Propagation of Different Amyloid-β Fibril Conformations
Spirig, T., Ovchinnikova, O. Y., Vagt, T., & Glockshuber, R. (2014) · Neurodegenerative Diseases · doi:10.1159/000363623 · Cited by 22
Amyloidogenesis: What Do We Know So Far?
Alraawi, Z., Banerjee, N., Mohanty, S., & Kumar, T. K. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213970 · Cited by 22
Watts, C. R., Gregory, A. J., Frisbie, C. P., & Lovas, S. (2017) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25270 · Cited by 21
Amyloid Beta Peptide Folding in Reverse Micelles
Eskici, G., & Axelsen, P. H. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b03333 · Cited by 20
de Souza, I. D., Anderson, J. L., Tumas, V., & Queiroz, M. E. C. (2022) · Talanta · doi:10.1016/j.talanta.2022.124186 · Cited by 21
Henriques, A. G., Domingues, S. C., Fardilha, M., Silva, E. F. D. C. E., & Silva, O. A. B. D. C. E. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-7302 · Cited by 23
Wu, B., Kitagawa, K., Zhang, N., Liu, B., & Inagaki, C. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02805.x · Cited by 22
“Such inhibition of PI3K, however, may not be involved in the pathogenesis of AD because the Ab-induced inhibition occurs at concentrations much higher than those in the brain of AD patients (< 10 nM, Seubert et al. 1992; Nakamura et al. 1994).”
ResultGrilli, M., Lagomarsino, F., Zappettini, S., Preda, S., Mura, E., Govoni, S. M., & Marchi, M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.01.058 · Cited by 20
Binding of Proteases to Fibrillar Amyloid-β Protein and its Inhibition by Congo Red
Chander, H., Chauhan, A., & Chauhan, V. P. S. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12308 · Cited by 22
“and patients with AD [2–4].”
The molecular significance of amyloid β-peptide for Alzheimer's disease
Haass, C. (1996) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02189111 · Cited by 21
Heinonen, O., Soininen, H., Syrjänen, S., Neittaanmäki, H., Paljärvi, L., Kosunen, O., Syrjänen, K., & Riekkinen, P. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540200075019 · Cited by 21
Kametania, F., Tanaka, K., Tokuda, T., & Ikeda, S. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00851-5 · Cited by 23
Mortimer, B., Redgrave, T. G., Spangler, E. A., Verstuyft, J. G., & Rubin, E. M. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1542 · Cited by 21
Glutamate, beta-amyloid precursor proteins, and calcium mediated neurofibrillary degeneration
Smith‐Swintosky, V. L., & Mattson, M. P. (1994) · Springer eBooks · doi:10.1007/978-3-7091-9350-1_3 · Cited by 24
Amyloid β protein and transthyretin, sequestrating protein colocalize in normal human kidney
Tsuzuki, K., Fukatsu, R., Hayashi, Y., Yoshida, T., Sasaki, N., Takamaru, Y., Yamaguchi, H., Tateno, M., Fujii, N., & Takahata, N. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)13369-9 · Cited by 22
Matsumoto, A., & Matsumoto, R. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.1055b.x · Cited by 20
Horák, D., Hlídková, H., Hiraoui, M., Taverna, M., Proks, V., Chánová, E. M., Smadja, C., & Kučerová, Z. (2014) · Macromolecular Bioscience · doi:10.1002/mabi.201400249 · Cited by 18
Supramolecular Structures of Amyloid-Related Peptides in an Ambient Water Nanofilm
Ye, M., Zhang, Y., Li, H., Xie, M., & Hu, J. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp105501x · Cited by 19
Tetrapeptide Ac-HAEE-NH2 Protects α4β2 nAChR from Inhibition by Aβ
Barykin, E. P., Garifulina, A. I., Tolstova, A. P., Anashkina, A. A., Adzhubei, A. A., Mezentsev, Y. V., Shelukhina, I. V., Kozin, S. A., Tsetlin, V. I., & Makarov, A. А. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176272 · Cited by 22
“The concentration of soluble Aβ species in the brain ranges from pM to nM [62,63], and peptide drugs are well-tolerated in hundreds of micromoles per liter, so the required concentration of Ac-HAEE-NH2 in the brain can probably be reached without adverse effects.”
BackgroundPlatelet Microparticles as Carriers of Soluble Alzheimer's Amyloid β (sAβ)
Matsubara, E., Shoji, M., Murakami, T., Abe, K., Frangione, B., & Ghiso, J. A. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04836.x · Cited by 21
Minogue, A. M., Stubbs, A. K., Frigerio, C. S., Boland, B., Fadeeva, J. V., Tang, J., Selkoe, D. J., & Walsh, D. M. (2009) · Brain Research · doi:10.1016/j.brainres.2009.01.008 · Cited by 23
Self-citationGrant, M. K. O., Handoko, M., Rózga, M., Brinkmalm, G., Portelius, E., Blennow, K., Ashe, K. H., Zahs, K. R., & Liu, P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212815 · Cited by 21
Navas-Carrillo, D., Rivera‐Caravaca, J. M., Sampedro-Andrada, A., & Orenes‐Piñero, E. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1833298 · Cited by 22
Assessing the Effects of Acute Amyloid β Oligomer Exposure in the Rat
Wong, R., Cechetto, D. F., & Whitehead, S. N. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091390 · Cited by 24
Vyas, S. B., & Duffy, L. K. (1995) · Journal of Protein Chemistry · doi:10.1007/bf01886902 · Cited by 20
Michno, W., Blennow, K., Zetterberg, H., & Brinkmalm, G. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15466 · Cited by 19
“…whether these approaches will aid in the characterization of lower order A β assemblies, such as soluble (Haass et al., 1992), and Seubert et al. (Seubert et al., 1992) and Shoji et al. (Shoji et al., 1992) used affinity chromatography with follow-up sequencing and IP-WB to show that A β was…”
MethodMarsool, M. D. M., Prajjwal, P., Reddy, Y. B., Marsool, A. D. M., Lam, J. R., & Nandwana, V. (2023) · Disease-a-Month · doi:10.1016/j.disamonth.2023.101547 · Cited by 24
A meta-analysis of the relationship between sleep and β-Amyloid biomarkers in Alzheimer’s disease
Harenbrock, J., Holling, H., Reid, G., & Koychev, I. G. (2023) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2023.100068 · Cited by 24
Tian, Y., Shang, Q., Liang, R., & Viles, J. H. (2024) · JACS Au · doi:10.1021/jacsau.3c00687 · Cited by 19
Biological markers of Alzheimer's disease
Mehta, P. D., & Pirttilä, T. (2002) · Drug Development Research · doi:10.1002/ddr.10063 · Cited by 18
Funke, S. A., Wang, L. G., Birkmann, E., & Willbold, D. (2009) · Rejuvenation Research · doi:10.1089/rej.2009.0925 · Cited by 18
Chaves, E. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-076 · Cited by 19
Cao, Y., Tang, X. L., Miao, Y., & Han, W. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.12.008 · Cited by 23
The nickel-chelator dimethylglyoxime inhibits human amyloid beta peptide in vitro aggregation
Benoit, S. L., & Maier, R. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-86060-1 · Cited by 19
Interaction of a β‐sheet breaker peptide with lipid membranes
Vitiello, G., Grimaldi, M., Ramunno, A., Ortona, O., Martino, G., D’Ursi, A. M., & D’Errico, G. (2010) · Journal of Peptide Science · doi:10.1002/psc.1207 · Cited by 18
Neuroinflammation and Alteration of the Blood-Brain Barrier in Alzheimer´s Disease
Soto-Rojas, L. O., de la Cruz‐López, F., Ontiveros‐Torres, M. Á., Viramontes‐Pintos, A., Cárdenas‐Aguayo, M. D. C., Meraz‐Ríos, M. A., Salinas‐Lara, C., Florán, B., & Luna‐Muñoz, J. (2015) · InTech eBooks · doi:10.5772/60024 · Cited by 23
Chronic psychosocial stress exposes Alzheimer s disease phenotype in a novel at-risk model
Karim, A. A. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/371 · Cited by 19
“secrete low levels of soluble Aβ peptides into cerebrospinal fluid (CSF) and plasma (32,33).”
BackgroundSchmitt, T. L., Steiner, E., Klingler, P. J., Lassmann, H., & Grubeck‐Loebenstein, B. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530592 · Cited by 18
Amyloidogenesis in familial British dementia is associated with a genetic defect on chromosome 13
GHISO, J., VIDAL, R., ROSTAGNO, A., MIRAVALLE, L., HOLTON, J. L., MEAD, S., RÉVÉSZ, T., PLANT, G., & FRANGIONE, B. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06908.x · Cited by 12
Unaltered Plasma Levels of β-Amyloid(1–40) and β-Amyloid(1–42) upon Stimulation of Human Platelets
Olsson, A., Vanmechelen, E., Vanderstichele, H., Davidsson, P., & Blennow, K. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000070681 · Cited by 21
Selective Cu2+/Ascorbate‐Dependent Oxidation of Alzheimer's Disease β‐Amyloid Peptides
Schöneich, C. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.013 · Cited by 19
Nordstedt, C., Näslund, J., Thyberg, J., Messamore, E., Gandy, S., & Terenius, L. Y. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36954-5 · Cited by 18
Evidence that glypican is a receptor mediating β-amyloid neurotoxicity in PC12 cells
Schulz, J. G., Megow, D., Reszka, R. C., Villringer, A., Einhäupl, K. M., & Dirnagl, U. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00220.x · Cited by 20
Stanyer, L., Betteridge, D. J., & Smith, C. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02646-7 · Cited by 19
Early onset Alzheimer's disease in a South American pedigree from Argentina
Mangone, C. A., Castaño, E. M., Levy, E., Abiusi, G., Wisniewski, T., Marques, M. R., Faccio, E., Gorelick, P. B., Frangione, B., & Sica, R. E. P. (1995) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1995.tb05835.x · Cited by 10
Vidal, R., Ghiso, J. A., Wısnıewskı, T., & Frangione, B. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00845-9 · Cited by 20
Probing modifications of the neuronal cytoskeleton
Doering, L. C. (1993) · Molecular Neurobiology · doi:10.1007/bf02769179 · Cited by 21
Lazo, N. D., Maji, S. K., Fradinger, E. A., Bitan, G., & Teplow, D. B. (2005) · Wiley eBooks · doi:10.1002/9783527619344.ch17 · Cited by 18
Introduction to Alzheimer's Disease
Allsop, D. (2003) · Humana Press eBooks · doi:10.1385/1-59259-195-7:1 · Cited by 18
Dwivedi, A. K., & Iyer, P. K. (2013) · Macromolecular Bioscience · doi:10.1002/mabi.201300107 · Cited by 18
Neurodegenerative disorders: Dysregulation of a carefully maintained balance?
Swart, C., Haylett, W. L., Kinnear, C. J., Johnson, G., Bardien, S., & Loos, B. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.09.003 · Cited by 23
“…between cognitive alterations and Aβ accumulation in AD is also not linear as was evident from studies in both humans (Price et al., 2009) and mice (Games et al., 1995); and concentrations of fibrillar Aβ needed to induce neuronal cell death in culture appeared excessive (Seubert et al., 1992).”
ResultMeyer, P., McSweeney, M., Gonneaud, J., & Villeneuve, S. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.05.001 · Cited by 22
New pathways in drug discovery for alzheimer’s disease
Siemers, E., Dean, R. A., Demattos, R. B., & May, P. C. (2006) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-996-0017-8 · Cited by 17
Structural differences of amyloid-β fibrils revealed by antibodies from phage display
Droste, P., Frenzel, A., Steinwand, M., Pelat, T., Thullier, P., Hust, M., Lashuel, H. A., & Dübel, S. (2015) · BMC Biotechnology · doi:10.1186/s12896-015-0146-8 · Cited by 23
“This processing results in peptides of various amino acids (aa) in length with the majority being 40 aa (90%) and 42 aa (10%) long [7], hence”
BackgroundDetecting beta-amyloid aggregation from time-resolved emission spectra
Alghamdi, A., Vyshemirsky, V., Birch, D. J. S., & Rolinski, O. J. (2017) · Methods and Applications in Fluorescence · doi:10.1088/2050-6120/aa9f95 · Cited by 20
Honda, R. P. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201800197 · Cited by 18
Cholesterol Modulates the Formation of the Aβ Ion Channel in Lipid Bilayers
Gao, Q., Wu, G., & Lai, K. W. C. (2020) · Biochemistry · doi:10.1021/acs.biochem.9b00968 · Cited by 17
Intracellular and cell-surface distribution of amyloid precursor protein in cortical astrocytes
Young, M. J., Lee, R. K. K., Jhaveri, S., & Wurtman, R. J. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00084-2 · Cited by 17
Liang, Y. Q., Huang, X. T., & Tang, X. C. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9158-9 · Cited by 21
“Much neuropathologic data supports this ‘‘amyloid hypothesis’’ (Seubert et al. 1992; Hardy 1997; Selkoe 2000).”
BackgroundProteolytic Degradation of the Amyloid β-Protein: The Forgotten Side of Alzheimers Disease
Leissring, M. A. (2006) · Current Alzheimer Research · doi:10.2174/156720506779025206 · Cited by 19
“Based on measurements of the rate of A production in cultured human neurons [4], it can be estimated that an individual will produce roughly”
BackgroundLeliveld, S. R., & Korth, C. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21353 · Cited by 19
“The most abundant fragments are Ab1– 40 and Ab1–42 which are produced independently of AD in the healthy individual and fulfill unknown functions (Seubert et al., 1992).”
BackgroundPosttranslational Arginylation of Brain Proteins
Hallak, M. E., & Bongiovanni, G. A. (1997) · Neurochemical Research · doi:10.1023/a:1027315912242 · Cited by 17
“Even though it has been shown that BAP1-40 is secreted by normal neuronal cultured cells (16) and can be detected in cerebrospinal fluid (17), its physiological role is not known.”
BackgroundPiracetam inhibits the lipid-destabilising effect of the amyloid peptide Aβ C-terminal fragment
Mingeot‐Leclercq, M., Lins, L., Bensliman, M., Thomas, A., Bambeke, F. V., Peuvot, J., Schanck, A. N., & Brasseur, R. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00654-5 · Cited by 21
Ma, M., Si, G., Lermontova, N. N., Kalyn, Y. B., Селезнева, Н. Д., Zharikov, G. A., Колыхалов, И. В., Абраменко, Т. В., Serkova, T. P., & Bachurin, S. O. (2001) · Bulletin of Experimental Biology and Medicine · doi:10.1023/a:1017527508878 · Cited by 17
Khorkova, O., Patel, K., Heroux, J. A., & Sahasrabudhe, S. R. (1998) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(98)00053-3 · Cited by 17
Moore, C. L., Diehl, T. S., Selkoe, D. J., & Wolfe, M. S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06922.x · Cited by 21
Self-citationVarshavskaya, K. B., Mitkevich, V. A., Makarov, A. А., & Barykin, E. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315036 · Cited by 23
“However, post-mortem tissue is not easily obtained, and the concentration of soluble oligomers in tissue extracts is low [12,13].”
BackgroundMesbah, K., Verpillot, R., Chiari, M., Pallandre, A., & Taverna, M. (2014) · The Analyst · doi:10.1039/c4an01296h · Cited by 19
Lazzaro, S., Ogrinc, N., Lamont, L., Vecchio, G., Pappalardo, G., & Heeren, R. M. A. (2019) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-02030-7 · Cited by 18
The Genetics of Alzheimer’s Disease and Parkinson’s Disease
Bekris, L. M., Yu, C., Bird, T. D., & Tsuang, D. W. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_21 · Cited by 19
“Second γ-secretases cleave APP (Haass et al., 1992; Seubert et al., 1992; Shoji et al., 1992).”
Isoform Specific Amyloid-β Protein Precursor Metabolism
Henriques, A. G., Vieira, S. I., Rebelo, S., Domingues, S. C., Silva, E. F. D. C. E., & Silva, O. A. B. D. C. E. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11112 · Cited by 18
Theory of Amyloid Fibril Nucleation from Folded Proteins
Zhang, L., & Schmit, J. D. (2017) · Israel Journal of Chemistry · doi:10.1002/ijch.201600079 · Cited by 18
Kareti, S. R., & Subash, P. (2020) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2020.05.035 · Cited by 19
Pharmacological Mechanisms in Alzheimer's Therapeutics
Cuello, A. C. (2007) · Springer eBooks · doi:10.1007/978-0-387-71522-3 · Cited by 18
Noonan, C. W., Reif, J. S., Burch, J. B., Ichinose, T. Y., Yost, M. G., & Magnusson, K. R. (2002) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-200208000-00012 · Cited by 16
A capillary electrophoresis method for evaluation of Aβ proteolysis in vitro
Alper, B. J., & Schmidt, W. K. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.11.010 · Cited by 18
“Soluble Aβ peptides are normally present within human plasma and cerebrospinal fluid, but under pathological conditions, these peptides accumulate within the brain, due to aggregation and fibrillogenesis (Seubert et al., 1992; Shoji et al., 1992; Hardy and Selkoe, 2002).”
Tsuzuki, K., Fukatsu, R., Takamaru, Y., Yoshida, T., Hayashi, Y., Yamaguchi, H., Fujii, N., & Takahata, N. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12205-2 · Cited by 16
Metadata
- Authors
- Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., McCormack, R., Wolfert, R., Selkoe, D., Lieberburg, I., & Schenk, D.
- Affiliations
- Austrian Academy of Sciences (AT)
- Venue
- Nature
- Published
- 1992-09
- Volume
- 359
- Issue
- 6393
- Pages
- 325-327
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2086278983
- Cited by
- 1,731
- References
- 28
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 32 · 2023: 19 · 2022: 22 · 2021: 31 · 2020: 28 · 2019: 25 · 2018: 35 · 2017: 39 · 2016: 31 · 2015: 48 · 2014: 46 · 2013: 39 · 2012: 50
- FWCI
- 72.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta, cerebrospinal fluid, plasma, conditioned medium, sandwich ELISA, affinity chromatography, epitope-specific antibodies, amyloid deposition, diagnostic biomarkers
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Antibodies, Monoclonal, Brain, Cells, Cultured, Cross Reactions, Enzyme-Linked Immunosorbent Assay, Humans, Molecular Sequence Data, Peptide Fragments, Radioimmunoassay, Solubility, Amyloid beta-Peptides, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.